THE EFFECTS OF GLICLAZIDE IN DIABETES - A COMPARISON WITH TOLBUTAMIDE

被引:5
作者
BERBER, MJ
TOMKIN, GH
机构
关键词
D O I
10.1007/BF02940142
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:46 / 49
页数:4
相关论文
共 12 条
[1]  
BURNSTEIN M, 1973, ADV LIPID RES, P67
[2]  
CALVERT GD, 1978, LANCET, V2, P66
[3]  
CHARBONNELL B, 1977, LANCET, V1, P464
[4]  
KAZAWOSIAN M, 1976, GAZETTE MED FRANCE, V83
[5]  
KEEN H, 1970, EARLY DIABETES
[6]  
KLAFF LJ, 1979, S AFR MED J, V56, P247
[7]   LIPOPROTEINS AND PLASMA-CHOLESTEROL ESTERIFICATION IN NORMAL AND DIABETIC SUBJECTS [J].
MATTOCK, MB ;
FULLER, JH ;
MAUDE, PS ;
KEEN, H .
ATHEROSCLEROSIS, 1979, 34 (04) :437-449
[8]  
PAASIKIVI J, 1970, ACTA MED SCAND S, P507
[9]   ANTI-PLATELET EFFECTS OF LONG-TERM TREATMENT WITH GLICLAZIDE IN DIABETIC-PATIENTS [J].
PONARI, O ;
CIVARDI, E ;
MEGHA, S ;
PINI, M ;
PORTIOLI, D ;
DETTORI, AG .
THROMBOSIS RESEARCH, 1979, 16 (1-2) :191-203
[10]   DIABETES - GENETIC CONNECTIONS [J].
PYKE, DA .
DIABETOLOGIA, 1979, 17 (06) :333-343